Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.913% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CCc1nn(CCCC(=O)NC(C)c2ccccc2)c(=O)c2cc3occc3n12
b. CCCCCCSc1cccc(-c2nc3ccc(C)cn3c2NCc2ccccc2)c1.O=C(O)C(F)(F)F
c. CCCc1nnc(NC(=O)CN2CCN(C)CC2)s1.Cl
Answer: c. CCCc1nnc(NC(=O)CN2CCN(C)CC2)s1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1nnc(NC(=O)CN2CCN(C)CC2)s1.Cl
CCCc1nnc(NC(=O)CN2CCN(C)CC2)s1.Cl
2-(4-methylpiperazin-1-yl)-N-(5-propyl-1,3,4-thiadiazol-2-yl)acetamide;hydrochloride